22 PHS Human Subjects and Clinical Trial Information Landin

PHS Human Subjects and Clinical Trials Information

I

0MB Number: 0925-0001 and 0925-0002

View Burden Statement ]

Expiration Date: 02/28/2023

Use of Human Specimens and/or Data
* Does any of the proposed research in the application involve human specimens and/or data?

0 Yes

0 No

Provide an explanation for any use of human specimens and/or data not considered to be human
subjects research.
Add Attachment

] [

Delete Attachment

] [

View Attachment

Please complete the human subjects section of the Research & Related Other Project Information form prior to completing this form.
The following items are taken from the Research and Related Other Project Information form and displayed here for your reference. Any changes
to these fields must be made on the Research & Related Other Project Information form and may impact the data items you are required to
complete on this form.
Are Human Subjects Involved?

0 Yes

Is the Project Exempt from Federal regulations?

O Yes

Exemption Number:

01

0 No
0 No
02

03

04

05

06

07

08

If No to Human Subjects
Skip the rest of the PHS Human Subjects and Clinical Trials Information Form
If Yes to Human Subjects
Add a record for each proposed Human Subject Study by selecting "Add New Study" or "Add New Delayed Onset Study" as appropriate. Delayed
onset studies are those for which there is no well-defined plan for human subject involvement at the time of submission, per agency policies on
Delayed Onset Studies. For delayed onset studies, you will provide the study name and a justification for omission of human subject study
information.
Other Requested Information
Add Attachment

] [

Delete Attachment

] [

View Attachment

Click here to extract the Human Subject Study Record Attachment
Study Record(s)
Attach human subject study records using unique filenames.

0 1) Please attach Human Subject Study 1

Add Attachment

J [

Delete Attachment

Add New Study
Delayed Onset Study(ies)

Study Title

[Kl

Add New Delayed Onset

Anticipated
Clinical Trial?

0

J

Justification

I

I

]

I

View Attachment